menu toggle

US Distributor Demands Better Biosimilars Support

Generics Bulletin, Aidan Fry

Removing legal hurdles and putting biosimilars on preferred formulary tiers will increase access and cut the cost of biologic therapies in the US, argues the chief of major healthcare distributor AmerisourceBergen.

For the full article, visit Generics Bulletin